Silent Method
New member
Background:
T3 FAQ: Everything you need to know about T3
Revised Formula for Cycling and Dosing T3
Liothyronine sodium (T3)
T3 ^ Attention Theorists, Users
This post is in effect an extension of my thread "T3 ^ Attention Theorists, Users."
It is accepted that T3 is best cycled in pyrimid configuration, a fairly quick ramp up to peak dose with emphasis being place on a smooth, and rather lengthy, tapering ramp down.
As of yet, I have seen no evidence supporting the necessity of the smooth, even down taper in regard to actual restoration of natural thyroid function. Instead, it seems that the only reason for this emphasis on the down taper is in effort to reduce the side effects of retarded thyroid function.
If this is so, might it not be better in regard to thyroid function recovery, for the T3 user to utilize a more aggressive "step down" phase? That is, upon cessation of the maximum dosage phase of the T3 cycle, might it not be favorable to step the dose down to a considerably less suppressive dose?
Consider the following:
234 555555555555555555555555 44444433333322222221111111.5.5.5.5.5.5.5
This happens to be a 60 day cycle following CYCLEON's 5% 40% 55% protocol. Conserving the respective protocol ratio, that is 5% up, 40% peak, and 55% down taper, but utilizing a more ggressive "step" down phase we might do this:
234 555555555555555555555555 2.5 2.5 2.5 2.5 2.5 2.5 111111111111.5.5.5.5.5.5.5 .25.25.25.25.25.25.25.25
So, whats the point in proposing this change anyway? Well, consider a statement I made before. "Let me say that I believe very strongly that interrupting any natural body system has the potential to harm that system. The longer the interruption, the greater the chance that harm will occur." Why not, then, attempt to more quickly reduce the highly suppressive levels of the drug?
Theoretically, by bringing the dose down faster and lessening the duration and severity of total thyroid shutdown, we can help facilitate a much more efficient recovery, but still provide enough exogenous T3 to lessen, or even eliminate side effects resulting from lagging thyroid output.
T3 FAQ: Everything you need to know about T3
Revised Formula for Cycling and Dosing T3
Liothyronine sodium (T3)
T3 ^ Attention Theorists, Users
This post is in effect an extension of my thread "T3 ^ Attention Theorists, Users."
It is accepted that T3 is best cycled in pyrimid configuration, a fairly quick ramp up to peak dose with emphasis being place on a smooth, and rather lengthy, tapering ramp down.
As of yet, I have seen no evidence supporting the necessity of the smooth, even down taper in regard to actual restoration of natural thyroid function. Instead, it seems that the only reason for this emphasis on the down taper is in effort to reduce the side effects of retarded thyroid function.
If this is so, might it not be better in regard to thyroid function recovery, for the T3 user to utilize a more aggressive "step down" phase? That is, upon cessation of the maximum dosage phase of the T3 cycle, might it not be favorable to step the dose down to a considerably less suppressive dose?
Consider the following:
234 555555555555555555555555 44444433333322222221111111.5.5.5.5.5.5.5
This happens to be a 60 day cycle following CYCLEON's 5% 40% 55% protocol. Conserving the respective protocol ratio, that is 5% up, 40% peak, and 55% down taper, but utilizing a more ggressive "step" down phase we might do this:
234 555555555555555555555555 2.5 2.5 2.5 2.5 2.5 2.5 111111111111.5.5.5.5.5.5.5 .25.25.25.25.25.25.25.25
So, whats the point in proposing this change anyway? Well, consider a statement I made before. "Let me say that I believe very strongly that interrupting any natural body system has the potential to harm that system. The longer the interruption, the greater the chance that harm will occur." Why not, then, attempt to more quickly reduce the highly suppressive levels of the drug?
Theoretically, by bringing the dose down faster and lessening the duration and severity of total thyroid shutdown, we can help facilitate a much more efficient recovery, but still provide enough exogenous T3 to lessen, or even eliminate side effects resulting from lagging thyroid output.